Allergan Agrees to Acquire Vicept Therapeutics in US$275 M Deal
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 7 (Table of Contents)
Published: 27 Jul-2011
DOI: 10.3833/pdr.v2011.i7.1513 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Allergan, best known for its Botox® (onabotulinumtoxinA) injection, has agreed to acquire privately held dermatology company Vicept Therapeutics in a deal worth up to US$275 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS